TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 30 filers reported holding TSCAN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 630,000 | $1,575,000 | 33.55% |
| Lynx1 Capital Management LP | 5,224,600 | $13,061,500 | 8.56% |
| Simplify Asset Management Inc. | 1,046,916 | $2,617,290 | 0.34% |
| EcoR1 Capital, LLC | 5,000,000 | $12,500,000 | 0.31% |
| Deer Management Co. LLC | 1,245,505 | $3,113,763 | 0.28% |
| Monashee Investment Management LLC | 400,000 | $1,000,000 | 0.24% |
| BVF INC/IL | 2,989,474 | $7,473,685 | 0.21% |
| Alphabet Inc. | 1,077,080 | $2,692,700 | 0.14% |
| DC Investments Management, LLC | 35,563 | $88,908 | 0.10% |
| Baker Brothers Advisors | 2,784,792 | $6,961,980 | 0.04% |